8/4/23 16:39 | 8/2/23 | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | Founder, | M.d | 2 | 0.0220 | 0 | 93 | 64 | 238 | D | | | | | | | | | | | | | | |
2/15/23 19:30 | 2/13/23 | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | M.d | 0 | 0.00 | 0 | 655 | 31 | 2,746 | D | | | | | | | | | | | | | | |
9/30/22 19:45 | 9/28/22 | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | CEO | M.d | 1 | 0.0011 | 0 | 750 | 56 | 2,091 | D | | | | | | | | | | | | | | |
1/5/22 21:45 | 12/31/21 | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | M.d | 0 | 0.0010 | 0 | 42 | 3 | 1,341 | D | | | | | | | | | | | | | | |
4/27/21 16:03 | 4/26/21 | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | P | 60 | 5.00 | 0 | 12 | 1 | 1,298 | D | | | | | | | | | | | | | | |
6/10/20 11:50 | 6/9/20 | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | P | 10 | 7.73 | 0 | 1 | 0 | 2,560 | D | | | | | | | | | | | | | | |
5/26/20 16:39 | 5/21/20 | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | P | 10 | 8.09 | 0 | 1 | 0 | 2,559 | D | | | | | | | | | | | | | | |
5/4/20 15:25 | 4/30/20 | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | P | 60 | 6.00 | 0 | 10 | 0 | 2,558 | D | | | | | | | | | | | | | | |